A brain tumor diagnosis can feel overwhelming. But knowing when surgery is necessary — and how to have the right convers ...

BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE)-- Rapport Therapeutics, Inc. (Nasdaq: RAPP) ("Rapport” or the "Company”), a clinical-stage biotechnology company dedicated to the discovery and ...

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...

Hackettstown, NJ-March is a time to refocus on healthy habits as we celebrate National Nutrition Month, an annual campaign created by the Academy of Nutrition and Dietetics to encourage people to make ...

The Belgian display tech company Barco makes some of the world’s finest projectors, used both in professional cinemas and in elite, megabuck home theater systems. (Michael Bay, the director of ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A routine shift took an unsettling turn for one woman after a guest ...

A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial results. The drug, called zorevunersen, holds promise, especially for people ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91 ...

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests. The anti-seizure medication, levetiracetam, was first approved ...

Find out what the Focal Mu-so Hekla all-in-one speaker can actually do, and why the company doesn’t want to call it a soundbar. Tuned by Focal and powered by Naim’s Pulse platform, Hekla delivers a ...